Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
From MaRDI portal
Publication:3442979
DOI10.1111/j.0006-341X.2004.00193.xzbMath1274.62820OpenAlexW2092241508WikidataQ48542394 ScholiaQ48542394MaRDI QIDQ3442979
Publication date: 25 May 2007
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/j.0006-341x.2004.00193.x
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items (6)
Stopping for efficacy in single-arm phase II clinical trials ⋮ Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials ⋮ Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials ⋮ Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping ⋮ Spatial two-stage designs for phase II clinical trials ⋮ Optimal adaptive two-stage designs for phase II cancer clinical trials
This page was built for publication: Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials